| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5604154 | International Journal of Cardiology | 2017 | 7 Pages |
Abstract
NOACs have a lower complication rate and appear to be safer in this setting than phenprocoumon. The hospital costs and hospital stay length after PVI was significantly reduced in patients treated with NOACs compared with phenprocoumon.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Ersan Akkaya, Alexander Berkowitsch, Sergej Zaltsberg, Nikolas Deubner, Harald Greiss, Andreas Hain, Christian W. Hamm, Johannes Sperzel, Malte Kuniss, Thomas Neumann,